ArticleFrontiers in immunology2026

A curcumin-borneol prodrug delays rheumatoid arthritis progression by inhibiting the activation of the MAPK/AP-1-MMP9 inflammatory axis.

Tianyi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.